These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 4543684)
1. Incidence of electrolyte disturbances on effects of the antiarrhythmic drugs. Kerkovits G Acta Cardiol; 1973; ():Suppl 17:155-6. PubMed ID: 4543684 [No Abstract] [Full Text] [Related]
2. ACE inhibitors and the heart: hypertrophy reversal and antiarrhythmic effects. Jones JV; James MA J Hum Hypertens; 1990 Oct; 4 Suppl 4():23-6; discussion 26-7. PubMed ID: 2149390 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drugs. Treatment of cardiac arrhythmias. Muir WW Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):957-87. PubMed ID: 1949502 [TBL] [Abstract][Full Text] [Related]
4. [To the mechanism of the anti-arrhythmic effect of pharmacological agents]. Senova ZP Farmakol Toksikol; 1966; 29(2):177-80. PubMed ID: 4386177 [No Abstract] [Full Text] [Related]
5. Desired mechanisms of drugs for ventricular arrhythmia: class III antiarrhythmic agents. Lipka LJ; Dizon JM; Reiffel JA Am Heart J; 1995 Sep; 130(3 Pt 1):632-40. PubMed ID: 7661091 [No Abstract] [Full Text] [Related]
6. Treatment of arrhythmia in patients with heart failure. Gottlieb SS Pacing Clin Electrophysiol; 1990 Nov; 13(11 Pt 2):1510-5. PubMed ID: 1702530 [No Abstract] [Full Text] [Related]
7. The experimental basis for the choice of an anti-arrhythmic drug. Vaughan Williams EM Adv Cardiol; 1970; 4():275-89. PubMed ID: 4395423 [No Abstract] [Full Text] [Related]
8. Arrhythmias and antiarrhythmic drugs: mechanism of action and structure-activity relationships II. Morgan PH; Mathison IW J Pharm Sci; 1976 May; 65(5):635-48. PubMed ID: 6770 [No Abstract] [Full Text] [Related]
9. [Cellular mechanisms of the etiology of cardiac rhythm disturbances and of the action of basic anti-arrhythmia drugs]. Lewartowski B; Kwiatkowska B Kardiol Pol; 1970; 13(4):341-7. PubMed ID: 4924744 [No Abstract] [Full Text] [Related]
10. [Cardiac arrhythmias (III). The classification of anti-arrhythmia drugs in the 90s: a focus for the cardiologist]. Tamargo J; Valenzuela C; Delpón E Rev Esp Cardiol; 1993 Mar; 46(3):183-94. PubMed ID: 8387683 [No Abstract] [Full Text] [Related]
17. [Clinical pharmacology of antiarrhythmic drugs]. Ambrosioni E G Clin Med; 1973 Jul; 54(7):407-28. PubMed ID: 4779854 [No Abstract] [Full Text] [Related]
18. Dyselectrolytemias and arrhythmias. Schiraldi F; Di Conza P; Guiotto G; Scott SW J Nephrol; 2010; 23 Suppl 16():S182-90. PubMed ID: 21170878 [TBL] [Abstract][Full Text] [Related]
19. Cellular aspects of antiarrhythmic activity. Carmeliet E Verh K Acad Geneeskd Belg; 1975; 37(5-6):229-50. PubMed ID: 1220361 [No Abstract] [Full Text] [Related]
20. Arrhythmias in patients with drug toxicity, electrolyte, and endocrine disturbances. Commerford PJ; Lloyd EA Med Clin North Am; 1984 Sep; 68(5):1051-78. PubMed ID: 6387326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]